Too much to hope for today Kei. Too bad Dr. Gottlieb was only asked about his progress re opioid drug removal initiative this morning on CNBC-TV, not his progress re implementing his[FDA's] low or no nicotine initiative re tobacco industry he discussed late July 2017 before RAPS.
hit new 52wk high yesterday (it was 84 cents last January)
22nd Century Group builds on rally, up 11% Jan. 18, 2018 3:50 PM ET|By: Douglas W. House, SA News Editor Plant biotech outfit 22nd Century Group (XXII +11.4%) continues its up move on double normal volume. Shares have rallied 90% since early November.
Next week, the FDA's Tobacco Products Scientific Advisory Committee will meet to discuss the modified risk tobacco applications from Philip Morris (MO -0.1%) (Wednesday and Thursday, 1/24 & 1/25).
A Phase 3 clinical trial evaluating 22nd's SPECTRUM Very Low Nicotine (VLN) cigarettes is ongoing. The estimated completion date is March.
Market Data 
Markets 
AI
